Cancer Research Technology Ltd. (CRT), Cancer Research U.K., The Institute of Cancer Research cancer news

The CRT Pioneer Fund announced that its first investment will be used to advance TTK protein kinase (TTK; MPS1) inhibitors into clinical testing to treat cancer. The compounds originate from Cancer ...